ArticleFrontiers in medicine2026

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases.

Xinhui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.